Telomere Diagnostics
Part of Orig3n
Is this your company?
Find the right fit for you - faster
Get tailored insights about working at Telomere Diagnostics in one quick step.
Telomere Diagnostics Snapshot
Biotech & PharmaceuticalsIndustry
Telomere Diagnostics, Inc. (TDx) is a privately held DNA testing company committed to helping people improve their cellular health.
TDx markets the TeloYears® actionable DNA test to help people stay younger and live longer by tracking their cellular age so they can optimize their telomere health. The age of one's cells in TeloYears is a simple yet comprehensive indicator of overall wellness. It is based on the length of one’s telomeres, the dynamic, protective caps on chromosomes that shorten with age, but also can change based on genetics, lifestyle, environment, stress, and other factors. More than 20,000 peer reviewed publications by some of America's most trusted institutions have established links between telomere length and cellular aging, age-related diseases, and mortality in general.
TDx was founded in 2010 by a group of four scientists, one of whom who was awarded the Nobel Prize in Medicine in 2009 for her pioneering work in telomere biology. Its lab in Silicon Valley (Menlo Park, California) is CLIA-certified under the Clinical Laboratory Improvement Amendments as qualified to perform high complexity clinical testing. TDx uses its own proprietary quantitative polymerase chain reaction (qPCR) assay, which is the world’s leading method of measuring Average Telomere Length (ATL).
Beyond TeloYears, the company is actively marketing TeloYears Advanced Ancestry, the world's first next generation sequencing-based ancestry test, and is also developing other potential uses of ATL to address unmet clinical needs in cardiovascular disease and beyond.
TDx markets the TeloYears® actionable DNA test to help people stay younger and live longer by tracking their cellular age so they can optimize their telomere health. The age of one's cells in TeloYears is a simple yet comprehensive indicator of overall wellness. It is based on the length of one’s telomeres, the dynamic, protective caps on chromosomes that shorten with age, but also can change based on genetics, lifestyle, environment, stress, and other factors. More than 20,000 peer reviewed publications by some of America's most trusted institutions have established links between telomere length and cellular aging, age-related diseases, and mortality in general.
TDx was founded in 2010 by a group of four scientists, one of whom who was awarded the Nobel Prize in Medicine in 2009 for her pioneering work in telomere biology. Its lab in Silicon Valley (Menlo Park, California) is CLIA-certified under the Clinical Laboratory Improvement Amendments as qualified to perform high complexity clinical testing. TDx uses its own proprietary quantitative polymerase chain reaction (qPCR) assay, which is the world’s leading method of measuring Average Telomere Length (ATL).
Beyond TeloYears, the company is actively marketing TeloYears Advanced Ancestry, the world's first next generation sequencing-based ancestry test, and is also developing other potential uses of ATL to address unmet clinical needs in cardiovascular disease and beyond.
